4 citations
,
January 2019 in “Egyptian Journal of Dermatology and Venereology” This study suggests that androgenetic alopecia moderately affects quality of life, with women experiencing a higher impact and showing a greater willingness to pay for treatment than men.
September 2019 in “Journal of Investigative Dermatology” This study found that patients with vitiligo report the highest willingness-to-pay for disease control and cure compared to those with other chronic skin conditions, suggesting DLQI may not fully capture treatment priorities.
16 citations
,
December 2019 in “Animals” In this study, cashmere goats engineered to overexpress the Tβ4 gene in hair follicles produced more cashmere, indicating that Tβ4 promotes secondary hair follicle development and enhances yield.
13 citations
,
March 2022 in “Patient Preference and Adherence” This study found that quality of life was significantly impaired among Chinese rosacea patients, especially those aged 21-40, with recent disease onset, appearance-dependent jobs, and severe symptoms.
December 2021 in “Cureus” This study found that for managing early-onset androgenetic alopecia in men, minoxidil monotherapy is cost-effective at a $50,000 willingness-to-pay threshold, while combining minoxidil with platelet-rich plasma becomes cost-effective at a $100,000 threshold.